Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/PIERIS-PHARMACEUTICALS-IN-22619465/news/Pieris-Pharmaceuticals-Inc-Announces-Dosing-of-First-Subject-in-Phase-1-Trial-of-Inhaled-CTGF-Inhi-42173951/?utm_source=whatsapp&utm_medium=social&utm_campaign=share